FDA Inspection 1337616 — Corey G. Anderson, M.D.
The FDA completed an inspection of Corey G. Anderson, M.D. on Sep 18, 2026 in Tempe, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 18, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tempe, AZ (United States)
Additional Details
Clinical BA/BE